Replies to post #4705 on Provectus Biopharmaceuticals Inc (PVCT)

[mackwheaton]

Swap your shares for ONCS on a Tuesday. Their melanoma data is outstanding, and the world will know at ASCO on June 2. Read the abstract . Bring you right back up.

[G Bert]

Could be any of the biggies playing behind the scenes. Politics and lobbying is rampant. An FDA advisory board may recommend one thing and later you will see final decision goes 180 in the other direction. So frustrating.